Your session is about to expire
← Back to Search
Bias Reduction Training for Rheumatic Diseases
N/A
Waitlist Available
Led By Candace H Feldman, MD, ScD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months following the encounter of interest
Awards & highlights
Study Summary
This trial will test if a provider-based intervention can improve care for Black/African American and lower socioeconomic status patients with rheumatic diseases.
Who is the study for?
This trial is for English-speaking Black or African American adults, or those with low socioeconomic status indicated by Medicaid/Mass Health insurance. Participants must be diagnosed with SLE or inflammatory arthritis like RA, have visited the provider less than twice in the past year, and be able to consent. Rheumatologists participating need at least one clinical session per week.Check my eligibility
What is being tested?
The study tests an individuation intervention combined with implicit bias education aimed at improving rheumatic disease care quality for certain demographics. It also examines how this approach affects communication between providers and patients, treatment adherence, trust in providers, and satisfaction with care.See study design
What are the potential side effects?
Since this trial focuses on educational modules and behavioral interventions rather than medications, traditional physical side effects are not applicable. However, participants may experience discomfort discussing personal biases.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months following the encounter of interest
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months following the encounter of interest
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of patients receiving high quality care
Secondary outcome measures
Adherence
Everyday Discrimination Scale
Implicit Association Test (IAT) scores
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1: Individuation Intervention plus implicit bias educationExperimental Treatment2 Interventions
10 rheumatologists who will have 10 patient interactions each (100 patients total) recorded Rheumatologists will watch implicit bias training modules and then will be instructed to incorporate an individuation strategy into each of their clinical encounters.
Group II: Arm 2: Implicit bias education onlyActive Control1 Intervention
10 rheumatologists randomized and stratified by hospital and gender
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,618 Previous Clinical Trials
11,471,492 Total Patients Enrolled
23 Trials studying Rheumatoid Arthritis
588,802 Patients Enrolled for Rheumatoid Arthritis
National Institute on Aging (NIA)NIH
1,676 Previous Clinical Trials
28,021,314 Total Patients Enrolled
5 Trials studying Rheumatoid Arthritis
256,485 Patients Enrolled for Rheumatoid Arthritis
Virginia Commonwealth UniversityOTHER
699 Previous Clinical Trials
22,884,860 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a rheumatologist with at least one clinical session per week at the specified locations.I am 18 or older, can consent, speak English, and have SLE or inflammatory arthritis. I've seen my provider less than 2 times last year.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 1: Individuation Intervention plus implicit bias education
- Group 2: Arm 2: Implicit bias education only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are additional participants needed for this research?
"According to the records on clinicaltrials.gov, this trial is not presently enrolling participants. It was first posted on June 17th 2022 and edited most recently on September 27th 2022. However, there are still 323 separate trials actively recruiting patients at this time."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger